May 2nd - 4th, 2018

Paris, France


2018 Programme - Paris

Sessions are tentative and subject to change. Last update: 12 March 2018.

Click here to view the programme in PDF.

2 May

10.45 - 13.00

MedTech Europe Ethics & Compliance Committee (ECC) Meeting (MEMBERS ONLY)
(Napoleon Room)

AdvaMed DDCG Meeting (Members ONLY)
(Concorde Ballroom)

SME Compliance Workshop (in French)  (confirmed)
(Aiglon Room)

13.00 - 14.00Lunch ECC-DDCG-SME Bootcamp
(Imperial Room)
14.00 - 15.45

MedTech Europe Ethics & Compliance Committee (ECC) Meeting (MEMBERS ONLY) - continuation
(Napoleon Room)

AdvaMed DDCG Meeting (Members ONLY) - continuation
(Concorde Ballroom)

SME Compliance Workshop - continuation
(Aiglon Room)

16.00 - 17.30Joint ECC-DDCG Meeting
(Concorde Ballroom)
18.00 - 19.30Welcome Reception & PwC Compliance Achievement Award Sponsored by PwC - confirmed
(Imperial Room)

3 May

09.00 - 09.30

Opening Remarks
(Concorde Ballroom)

Moderator: Ingmar de Gooijer (invited)


  • Roeland Van Aelst, VP Healthcare Compliance EMEA & Canada, Johnson & Johnson and chairman of the MTE Ethics & Compliance Committee (confirmed)
  • Bronwen Taylor, Vice President, Compliance & Risk Management, Stryker and chairwoman of the AdvaMed DDCG (confirmed)

Description: The two associations’ Compliance Chairpersons will discuss MedTech Europe & AdvaMed priorities, including the key priority of Code compliance and how this topic underpins all other themes addressed by the industry. Issues such as Code convergence will also be addressed.

09.30 - 10.00

Keynote Speech - Considerations for industry
(Concorde Ballroom)

  • Renaud Jaune, Deputy Director, French Anti-Corruption Agency (AFA) (confirmed)
10.00 - 10.45

CEO Panel
(Concorde Ballroom)


  • Michelle Brennan, Company Group Chair, Medical Devices EMEA, Johnson & Johnson and Chairwoman of the MedTech Europe's Board of Directors (confirmed)
  • David Perez, President & CEO, Terumo BCT, Chairman, Blood Management Business (confirmed)

Moderator: Ingmar de Gooijer

Description: MedTech senior executives share thoughts on ethics and compliance; explain how they voice the compliance "tone at the top;" comment on the value and role of compliance within a MedTech company and comment on the role of trade associations in ethics and compliance. This panel will also examine CEOs’ perspectives on current trends in compliance (e.g. relationships with patient organisations, transparency, value-based healthcare and the direct sponsorship phase-out).

10.45 - 11.15Networking break
(Imperial-Aiglon Room)
11.15 - 12.30

Plenary 1 - “HealthTech – what does it mean for compliance?”
(Concorde Ballroom)


  • Ted Acosta, Vice Chair, Risk Management, EY (confirmed)
  • Oba Adewunmi, Legal Counsel, Verily Life Science (invited)
  • Trish Gatley, Compliance, Illumina (confirmed)
  • Carsten Fischer, Legal Counsel EMEA, AGFA (invited) 

Moderator: Ingmar de Gooijer

Description: HealthTech could be defined as the use of technology (e.g. databases, applications, services, mobiles, wearables) to improve the delivery, payment, and/or consumption of care, with the ability to increase the development and commercialization of more traditional MedTech products. For companies, the implications are profound, and these new commercial models present opportunities but also significant challenges. There is also an ever-growing set of regulatory guidelines, which are often outdated before they enter into force. Where do these companies stand on the issue of compliance? What can the traditional MedTech industry learn from them? What can we learn from each other? The discussion will go beyond privacy to explore the interaction of these new business models, with new risks such as corruption/inducement; direct interactions with patients; competition law and tax aspects.
12.30 - 13.30

Networking lunch 
(Imperial-Aiglon Room)

13.30 - 15.00

Parallel Session 1: Legal & Compliance Risks of Public-Private Partnerships
(Napolean Room)



  • Els Janssens, Associate, Baker & McKenzie (confirmed)
  • Enno Behrendt, Legal and Compliance, Siemens Healthcare GmbH (confirmed)
  • Anne-Sophie Bricca, Compliance, Terumo BCT (confirmed)

Description: Governments all over the world, but particularly in high growth markets, encounter budget restrictions, while at the same time seeking to compete to further improve quality of care, access to innovation and expertise. One model that these governments are therefore looking at is Healthcare Public Private Partnerships (PPP). Though the number of actual projects remains limited, this panel will explore the lessons that have been learned and build on existing expertise, to discuss the legal and compliance risks of such PPPs.

Parallel Session 2: Distributor compliance: can have, wanna have, must have?
(Vendome Room)


  • Antje Doether, VP Compliance Officer, Smith and Nephew (confirmed)
  • Kevin Espinoza, Vice President, Global Compliance Officer, BTG (confirmed)
  • Nadège Rochel, Regional Compliance Officer, Hollister (confirmed)

Moderator: Scott Lane, Executive Chairman, The Red Flag Group (confirmed)

Description: This panel aims at discussing the regulatory changes in their broadest sense and what this means for distributors and their relationship with MedTech companies, considering the different types of relationships that exist. In addition, the panel will review how to meet mutual expectations, through innovative means (e.g. “Compliance in a Box" programs). 

Parallel Session 3: Leveraging Governmental Affairs strategies to drive compliance objectives
(Tuileries Room)

Speaker: Simon Levitt, Founder and Partner, Harwood Levitt Consulting (confirmed)

Description: This session is designed as a brainstorming and skill-building session to discuss how the industry can be more effective in shaping national legislation to avoid legislation which is not fit for purpose from a compliance perspective (e.g. transparency laws). Aspects such collaboration between Public Affairs and Compliance teams shall be addressed as well.

15.00 - 15.30

Networking Break
(Imperial-Aiglon Room)

15.30 - 17.15

Ask the Experts session
(Concorde Ballroom)

Main Moderator: Michael Koon, Partner, Norton Rose Fulbright (confirmed)

Description: This session will be set up in roundtable discussions. The time allocated will allow them to get to the heart of key issues. Attendance is limited to 12 persons per table. After 40 minutes, the participants are invited to switch tables. Each table lead will prepare in advance a one-pager with key topics/trends that they plan to address. After the discussions, key discussion points/outcome will be added to this one-pager and circulated to all participants.

Topics & Table Leads:

  • Applying the MedTech Europe Code in France: Olivier Sudre, HealthCare Compliance & Transparency Officer, Johnson & Johnson (confirmed)
  • MedTech Europe Transparency: Pablo Abad, Legal & Compliance Manager, MedTech Europe (confirmed)
  • Third Party SMI / Distributors: Scott Lane, Executive Chairman, The Red Flag Group (confirmed)
  • Middle East: Ghadeer Al Yacoub, JnJ & Mecomed (confirmed) & Arwa Asiri, Ethical MedTech (confirmed)
  • EFPIA Disclosure and Transparency: Julie Bonhomme, Legal Affairs and Compliance Director, EFPIA (confirmed)
  • Turkey: Esra Akyol Bilgin, Health Care Compliance Officer, J&J Medical Devices and Consumer Turkey (invited)
  • China
  • GDPR / Privacy
18.00 - 19.30

Welcome Cocktail with US Ambassador Jamie McCourt

Venue: Hôtel de Talleyrand – George Marshall Center (Paris)

Sponsor: Ernst and Young (confirmed)

20.00 - 22.30

GMTCC Networking Dinner

Venue: Restaurant La Gare (Paris)

Sponsor: Red Flag (confirmed)

4 May

8.00 - 9.00Registration & Welcome Coffee
(Imperial-Aiglon Room)
8.00 - 9.00Breakfast meeting for Healthcare Organisations & Professionals Conference Organisers (confirmed)
09.00 - 10.15

Plenary 2: What is the value of compliance?
(Concorde Ballroom)


  • Carlos Gouvêa, Executive Director, Ethics Health Institute & Executive President, CBDL (Câmara Brasileira de Diagnóstico Laboratorial) (confirmed)
  • Erinn Hutchinson, Principal, PwC (confirmed)
  • David Perez, President and CEO, Terumo BCT (confirmed)
  • Kim Weistra, Sector leader Social Affairs & Health, Ecorys (confirmed)

Moderator: Ingmar de Gooijer

Description: This panel will address the value of compliance for a country, for patients, for a healthcare system and also for a company (e.g. which KPIs and is the absence of consequences enough?). Speakers will discuss the perception of stakeholders on the MedTech industry's brand equity and ask: What are the key challenges? Have codes changed stakeholders' perspective and perception? What risk metrics do define an ethical business environment?

10.15 - 10.45Networking break
(Imperial-Aiglon Room)
10.45 - 12.30

Parallel Session 1: Exchange of best practices on Educational Grants around the world
(Napoleon Room)


  • Esra Akyol Bilgin, Health Care Compliance Officer, J&J Medical Devices and Consumer Turkey (confirmed)
  • Campbell Clark, Chief Ethics & Compliance Oicer, Asia Pacific, Medtronic Singapore (confirmed)
  • Denis Jacob, Director, Ethics & Compliance International, BD (confirmed)
  • Elke Louwette, Congress & Event, WL Gore (confirmed)


Description: With the phase-out of direct sponsorship in many jurisdictions across the world since the beginning of the year, companies are restructuring their strategies to support general education of healthcare practitioners as well as processes around educational grants. This panel will provide insights as to what has worked - and not - for different players worldwide.

Parallel Session 2: Value-based healthcare: what are the legal and compliance issues?
(Vendome Room)


  • Aline SAMSON-DYE, Legal Counsel, UniHA, French Public Hospitals Network (confirmed)


Description: To follow up on last year’s conference discussion on the profound transformational shift toward value-based healthcare, this panel will discuss the legal and compliance opportunities and challenges these new commercial models present and how organisations such as MedTech Europe and AdvaMed can help support their members.

Parallel Session 3: Are the seven FCPA elements enough?
(Tuileries Room)



Description: Recent European legislators seem to have gone a step further than the DOJ in regulating what they expect a good compliance program to be. This panel will start with mapping some of the recent legislative moves and discuss how to ensure that companies comply with the multiplicity of requirements.

12.30 - 13.45

Networking Lunch
(Imperial-Aiglon Room)

13.45 - 15.00

Plenary session 3: A view from the other side- looking critically at the ethics of healthcare
(Concorde Ballroom)


  • Diane Biagianti, VP, Chief Responsibility Officer, Edwards Lifesciences (confirmed)
  • BEUC (invited)
  • EPHA (invited)

Moderator: Ingmar de Gooijer

Description: How do patients organisations and healthcare watchdogs judge the success of the ethics and compliance efforts of the MedTech industry? What is their advice on the key issues, potential conflicts of interests and how to best address them? What is their stand on transparency (e.g. who is responsible? How far should it go?).

15.00 - 15.15

Plenary session: Closing remarks & discussions
(Concorde Ballroom)


  • Roeland Van Aelst, VP Healthcare Compliance EMEA & Canada, Johnson & Johnson and chairman of the MTE Ethics & Compliance Committee (invited)
  • Bronwen Taylor, Vice President, Compliance & Risk Management, Stryker and chairwoman of the AdvaMed DDCG (confirmed)

Moderator: Ingmar de Gooijer